These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evaluation of the third trimester amniocentesis for fetal karyotyping in women with fear of pregnancy loss]. Picone O; Fuchs F; Sénat MV; Brisset S; Tachdjian G; Audibert F; Fernandez H; Frydman R J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):385-91. PubMed ID: 18191913 [TBL] [Abstract][Full Text] [Related]
3. Previous induced abortions and the risk of very preterm delivery: results of the EPIPAGE study. Moreau C; Kaminski M; Ancel PY; Bouyer J; Escande B; Thiriez G; Boulot P; Fresson J; Arnaud C; Subtil D; Marpeau L; Rozé JC; Maillard F; Larroque B; BJOG; 2005 Apr; 112(4):430-7. PubMed ID: 15777440 [TBL] [Abstract][Full Text] [Related]
4. Maternal second-trimester serum ferritin concentrations and subsequent risk of preterm delivery. Xiao R; Sorensen TK; Frederick IO; El-Bastawissi A; King IB; Leisenring WM; Williams MA Paediatr Perinat Epidemiol; 2002 Oct; 16(4):297-304. PubMed ID: 12445145 [TBL] [Abstract][Full Text] [Related]
5. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Borgida AF; Mills AA; Feldman DM; Rodis JF; Egan JF Am J Obstet Gynecol; 2000 Oct; 183(4):937-9. PubMed ID: 11035342 [TBL] [Abstract][Full Text] [Related]
6. Indicated versus spontaneous preterm delivery: An evaluation of neonatal morbidity among infants weighing =1000 grams at birth. Kimberlin DF; Hauth JC; Owen J; Bottoms SF; Iams JD; Mercer BM; Thom EA; Moawad AH; VanDorsten JP; Thurnau GR Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 1):683-9. PubMed ID: 10076148 [TBL] [Abstract][Full Text] [Related]
7. The relationship between oligohydramnios and the onset of preterm labor in preterm premature rupture of membranes. Park JS; Yoon BH; Romero R; Moon JB; Oh SY; Kim JC; Jun JK Am J Obstet Gynecol; 2001 Feb; 184(3):459-62. PubMed ID: 11228503 [TBL] [Abstract][Full Text] [Related]
8. Fear of pregnancy loss and fetal karyotyping: a place for third-trimester amniocentesis? Picone O; Senat MV; Rosenblatt J; Audibert F; Tachdjian G; Frydman R Fetal Diagn Ther; 2008; 23(1):30-5. PubMed ID: 17934295 [TBL] [Abstract][Full Text] [Related]
9. Complications of third-trimester amniocentesis using continuous ultrasound guidance. Gordon MC; Narula K; O'Shaughnessy R; Barth WH Obstet Gynecol; 2002 Feb; 99(2):255-9. PubMed ID: 11814506 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome after third trimester amniocentesis: a single center experience. Gabbay-Benziv R; Yogev Y; Melamed N; Ben-Haroush A; Meizner I; Pardo J J Matern Fetal Neonatal Med; 2012 Jun; 25(6):666-8. PubMed ID: 21834751 [TBL] [Abstract][Full Text] [Related]
12. Congenital anomalies are an independent risk factor for neonatal morbidity and perinatal mortality in preterm birth. Linhart Y; Bashiri A; Maymon E; Shoham-Vardi I; Furman B; Vardi H; Mazor M Eur J Obstet Gynecol Reprod Biol; 2000 May; 90(1):43-9. PubMed ID: 10767509 [TBL] [Abstract][Full Text] [Related]
13. The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Johnson MP; Bennett KA; Rand L; Burrows PK; Thom EA; Howell LJ; Farrell JA; Dabrowiak ME; Brock JW; Farmer DL; Adzick NS; Am J Obstet Gynecol; 2016 Dec; 215(6):778.e1-778.e9. PubMed ID: 27496687 [TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity. Chaiworapongsa T; Romero R; Espinoza J; Kim YM; Edwin S; Bujold E; Gomez R; Kuivaniemi H J Matern Fetal Neonatal Med; 2005 Dec; 18(6):405-16. PubMed ID: 16390807 [TBL] [Abstract][Full Text] [Related]
15. The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study. Zeitlin J; Ancel PY; Saurel-Cubizolles MJ; Papiernik E BJOG; 2000 Jun; 107(6):750-8. PubMed ID: 10847231 [TBL] [Abstract][Full Text] [Related]
16. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Ghezzi F; Franchi M; Raio L; Di Naro E; Bossi G; D'Eril GV; Bolis P Am J Obstet Gynecol; 2002 Feb; 186(2):268-73. PubMed ID: 11854648 [TBL] [Abstract][Full Text] [Related]
17. Maternal asthma and risk of preterm delivery. Sorensen TK; Dempsey JC; Xiao R; Frederick IO; Luthy DA; Williams MA Ann Epidemiol; 2003 Apr; 13(4):267-72. PubMed ID: 12684193 [TBL] [Abstract][Full Text] [Related]
18. The fetal inflammatory response syndrome. Gomez R; Romero R; Ghezzi F; Yoon BH; Mazor M; Berry SM Am J Obstet Gynecol; 1998 Jul; 179(1):194-202. PubMed ID: 9704787 [TBL] [Abstract][Full Text] [Related]
19. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Yoon BH; Oh SY; Romero R; Shim SS; Han SY; Park JS; Jun JK Am J Obstet Gynecol; 2001 Nov; 185(5):1162-7. PubMed ID: 11717651 [TBL] [Abstract][Full Text] [Related]
20. Comparison study between induced and spontaneous term and preterm births of small-for-gestational-age neonates. Hershkovitz R; Erez O; Sheiner E; Bashiri A; Furman B; Shoham-Vardi I; Mazor M Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):141-6. PubMed ID: 11451538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]